Restrictive Lung Disease

Total Page:16

File Type:pdf, Size:1020Kb

Restrictive Lung Disease Downloaded from https://academic.oup.com/ptj/article/48/5/455/4638136 by guest on 29 September 2021 RESTRICTIVE LUNG DISEASE WARREN M. GOLD, M.D. RESTRICTIVE LUNG DISEASE is a These disorders can be divided into two pattern of abnormal lung function defined by groups: extrapulmonary and pulmonary. a decrease in lung volume (Fig. I).1,2 The In extrapulmonary restriction, an abnormal total lung capacity is decreased and, in severe increase in the stiffness of the chest wall (kypho­ restrictive defects, all of the subdivisions of the scoliosis) restricts the lung volumes, as does total lung capacity including vital capacity, respiratory muscle weakness (poliomyelitis or functional residual capacity, and residual vol­ muscular dystrophy). These extrapulmonary ume are decreased. In mild or moderately se­ causes of pulmonary restriction are treated vere restrictive defects, the residual volume may be normal or slightly increased. CLINICAL DISORDERS CAUSING TABLE 1 RESTRICTIVE LUNG DISEASE CAUSES OF RESTRICTIVE LUNG DISEASE Restrictive lung disease is not a specific clin­ I. Extrapulmonary restriction 3 ical entity, but only one of several patterns of A. Chest wall stiffness (kyphoscoliosis) B. Respiratory-muscle weakness (muscular dystrophy)4 abnormal lung function. It is produced by a C. Pleural disease (pneumothorax)5 number of clinical disorders (see Table 1). II. Pulmonary restriction A. Surgical resection (pneumonectomy)6.7 Dr. Gold: Director, Pulmonary Laboratory and Re­ B. Tumor (bronchogenic carcinoma or metastatic tumor)8 search Associate in Cardiology (Pulmonary Physiology), C. Heart disease (hypertensive, arteriosclerotic, rheu­ Children's Hospital Medical Center; Associate in Pedi­ matic, congenital)9 atrics and Tutor in Medical Science, Harvard Medical 10 11 School, Boston, Massachusetts. D. Pneumonia (viral, bronchial, lobar) . Presented at the Symposium on Chest Disorders in Chil­ E. Granulomatous disorder (sarcoidosis, tuberculosis, dren. fungal infections)12 This work was done during the tenure of an Advanced F. Pneumoconiosis (silicosis, asbestosis)13-14 Research Fellowship of the American Heart Association. G. Diffuse interstitial fibrosis (Hamman-Rich syndrome)15 This work was supported in part by Grant HE-10436 H. Collagen disease (lupus erythematosis, scleroderma)16 from the National Heart Institute of the National Institute I. Atelectasis 17>19 of Health. Volume 48 / Number 5 455 Lung Volumes Normal Restrictive Lung Disease Downloaded from https://academic.oup.com/ptj/article/48/5/455/4638136 by guest on 29 September 2021 Fig. 1. A normal spirogram (left) is depicted in relation to the total lung capacity (TLC), vital capacity (VC), junctional residual capacity (FRC=ERV 4- RV), inspiratory capacity (IC), expiratory reserve volume (ERV), and residual volume (RV). A spirogram of the type observed in restrictive lung disease is superimposed on the normal TLC (right). Note the dif­ ference in pattern of respiration (rapid and shallow). RESTRICTIVE LUNG DISEASE PATHOPHYSIOLOGY OF RESTRICTIVE LUNG DISEASE separately in this symposium.18 Any disorder Lung Volumes of the pleural space (pleural effusion, pneumo­ The vital capacity (the maximum volume thorax, or fibrothorax) can also lead to a loss of air expired after a maximum inspiration) is of lung volume. always decreased in restrictive lung disease. Pulmonary restriction includes any disorder However, this test of lung volume depends on which causes an actual loss of lung tissue the effort and co-operation of the patient. (tumor, pneumonectomy), loss of air-contain­ Furthermore, it may be abnormally decreased ing alveoli (pulmonary edema or pneumonia), if the residual volume is abnormally increased or loss of lung distensibility (fibrosis, sarcoid­ (hyperinflation) secondary to airway obstruc­ osis, collagen disease). This pattern may tion. It is important, therefore, in the physio­ also result from any of the disorders that pro­ logic diagnosis of pulmonary restriction to duce obstructive airway disease (asthma, measure the total lung capacity (Fig. 2). In bronchitis, cystic fibrosis) when complicated most pulmonary laboratories, this measure­ by atelectasis. The role of the physical ther­ ment is made by a gas dilution method such apist is so important in the treatment of atelec­ as the open-circuit N2 washout method illus­ tasis that this condition is also considered trated in Figure 2, or by a plethysmographic separately in this symposium.10 method. 456 PHYSICAL THERAPY >r 0 Liters Room Air Downloaded from https://academic.oup.com/ptj/article/48/5/455/4638136 by guest on 29 September 2021 30 Liters Cone. = 4% Fig. 2. There are several methods of determining the volume of gas which cannot be expired, but most laboratories use an open-circuit N2 washout method. The volume of gas in the lungs is unknown. When the patient breathes room air, however, this gas is known to contain 80 per cent N2. The amount of N2 in his lungs is determined by washing all the N2 out of the lungs with N2-free 02. The patient inspires 02 and expires through a suitable valve system into a Nz- free spirometer (previously flushed with 02) where the volume and N2 concentration of the expired gas is measured. At the beginning of the test all the N2 is in the lungs (grey circles); at the end of the test all the N2 is in the spirometer which contains 30,000 ml of gas and N2 conc. — 4 per cent. The spirometer contains 0.04 X 30,000 ml •=. 1200 ml N2. All this N2 came from the lungs; since 1200 ml N2 existed in the lungs as 80 per cent N,, then the volume 80 of gas in the alveoli at the start of the test was 1200 X JQQ — 1500. Corrections must be made in this volume for small amounts of N2 in the 02 which the subject inspires and for the blood and tissue N2 washed out during the procedure. Volume 48 / Number 5 457 RESTRICTIVE LUNG DISEASE must be applied to them sufficient to overcome the force with which the springs recoil.* If a second set of stiffer springs is stretched, they Lung Elastic Recoil generate an even greater recoil force. To Many of the disorders listed in Table 1 not stretch these "stiff" springs to the same length only cause a loss of lung volume, but also alter as the "normal" springs, a much greater force the distensibility of the lungs; the lungs be­ must be applied than was used with the come stiffer than normal.20 The process of "normal" springs. lung inflation is analogous to stretching a set The parenchyma of the lung behaves like of springs (Fig. 3). If the "springs" in Figure a set of springs tending to recoil to its resting 3 are stretched from their rest length (Li) to length (Fig. 4). Stretching the "lung springs" a greater length (L2), they tend to recoil to their resting length with a certain force (F= * An elastic material returns to its original form when Downloaded from https://academic.oup.com/ptj/article/48/5/455/4638136 by guest on 29 September 2021 the force distorting it is removed. The stretching force recoil force). To stretch the springs, a force on a set of springs is therefore called an elastic force. "Normal" Springs "Stiff" Springs /VM /W\A, < L, 4 •< Lji »' B. Length F, F. Force £ Fig. 3. (A) Comparison of "normal" and "stiff" springs. Rest length = Lx, stretched length = L2; recoil force of "normal" springs = F,, recoil force of stiff springs = Fs. (B) Length-force relationships of "normal" and "stiff" springs. To stretch the "stiff" springs a distance equal to the normal springs requires a greater force. Note that the slope of the stiff spring line is decreased compared to the slope of the normal line. 458 PHYSICAL THERAPY A. "Normal" B. Stiff IWWV W\AA/1 PAPP v PAPP ; V, rAA/W/n 5 p; AAAAA AAAAAAA VWW\A PAPP v, PAPP- : V2 Downloaded from https://academic.oup.com/ptj/article/48/5/455/4638136 by guest on 29 September 2021 Q\ '5 P' LA/WWV 2 •WWV\J Volume Pressure Fig. 4. (A) ELASTIC RECOIL PRESSURE OF THE LUNG. The lung is represented by a bellows with a "springs" in its walls. The elastic recoil pressure (P) generated by these lung springs is measured by the manometer in the tube leading to the bellows. The applied pressure (Papp) is supplied by a piston in the tube. Vi and V2 are two different lung volumes, Pt and P2 are the corresponding recoil pressures. The stiff lungs on the right generate a greater-than-normal recoil pressure P' at any lung volume. (B) ELASTIC RECOIL CURVE OF THE LUNG. Volume is on the ordinate and pressure on the abscissa. Note that the stiff lung requires a greater pres­ sure to distend it to the same volume as the normal lung. The slope of the pressure-volume , change in volume . ....... , curve or lung compliance (C = —2—: ) is diminished in the stiff lung. L change in pressure produces a volume change and generates a may be applied by a ventilator, or by the pressure which makes the lung recoil to its anesthesiologist's hand on the anesthesia bag. resting volume. The magnitude of this elastic Many of the disorders listed in Table 1 change recoil pressure depends on the volume of air the distensibility characteristics of the lung so put into the lung. The more the lung is dis­ that it becomes stiffer than normal (Fig. 4). tended, the greater the recoil pressure generated This means that the elastic recoil curve of the by the "lung springs." To distend the lung, lung is altered (shifted to the right and below a pressure must be applied that is sufficient to the normal range) so that at any given volume, overcome this recoil pressure. This applied the "stiffer" lung requires a greater than pressure is usually produced by the muscles normal pressure to produce a comparable de­ of respiration, but in the patient, this pressure gree of distention or volume.
Recommended publications
  • Peak Flow Measure: an Index of Respiratory Function?
    International Journal of Health Sciences and Research www.ijhsr.org ISSN: 2249-9571 Original Research Article Peak Flow Measure: An Index of Respiratory Function? D. Devadiga, Aiswarya Liz Varghese, J. Bhat, P. Baliga, J. Pahwa Department of Audiology and Speech Language Pathology, Kasturba Medical College (A Unit of Manipal University), Mangalore -575001 Corresponding Author: Aiswarya Liz Varghese Received: 06/12/2014 Revised: 26/12/2014 Accepted: 05/01/2015 ABSTRACT Aerodynamic analysis is interpreted as a reflection of the valving activity of the larynx. It involves measuring changes in air volume, flow and pressure which indicate respiratory function. These measures help in determining the important aspects of lung function. Peak expiratory flow rate is a widely used respiratory measure and is an effective measure of effort dependent airflow. Aim: The aim of the current study was to study the peak flow as an aerodynamic measure in healthy normal individuals Method: The study group was divided into two groups with n= 60(30 males and 30 females) in the age range of 18-22 years. The peak flow was measured using Aerophone II (Voice Function Analyser). The anthropometric measurements such as height, weight and Body Mass Index was calculated for all the participants. Results: The peak airflow was higher in females as compared to that of males. It was also observed that the peak air flow rate was correlating well with height and weight in males. Conclusions: Speech language pathologist should consider peak expiratory airflow, a short sharp exhalation rate as a part of routine aerodynamic evaluation which is easier as compared to the otherwise commonly used measure, the vital capacity.
    [Show full text]
  • Spirometry Basics
    SPIROMETRY BASICS ROSEMARY STINSON MSN, CRNP THE CHILDREN’S HOSPITAL OF PHILADELPHIA DIVISION OF ALLERGY AND IMMUNOLOGY PORTABLE COMPUTERIZED SPIROMETRY WITH BUILT IN INCENTIVES WHAT IS SPIROMETRY? Use to obtain objective measures of lung function Physiological test that measures how an individual inhales or exhales volume of air Primary signal measured–volume or flow Essentially measures airflow into and out of the lungs Invaluable screening tool for respiratory health compared to BP screening CV health Gold standard for diagnosing and measuring airway obstruction. ATS, 2005 SPIROMETRY AND ASTHMA At initial assessment After treatment initiated and symptoms and PEF have stabilized During periods of progressive or prolonged asthma control At least every 1-2 years: more frequently depending on response to therapy WHY NECESSARY? o To evaluate symptoms, signs or abnormal laboratory tests o To measure the effect of disease on pulmonary function o To screen individuals at risk of having pulmonary disease o To assess pre-operative risk o To assess prognosis o To assess health status before beginning strenuous physical activity programs ATS, 2005 SPIROMETRY VERSUS PEAK FLOW Recommended over peak flow meter measurements in clinician’s office. Variability in predicted PEF reference values. Many different brands PEF meters. Peak Flow is NOT a diagnostic tool. Helpful for monitoring control. EPR 3, 2007 WHY MEASURE? o Some patients are “poor perceivers.” o Perception of obstruction variable and spirometry reveals obstruction more severe. o Family members “underestimate” severity of symptoms. o Objective assessment of degree of airflow obstruction. o Pulmonary function measures don’t always correlate with symptoms. o Comprehensive assessment of asthma.
    [Show full text]
  • Learning Objectives
    Restrictive Lung Diseases & Pulmonary Vascular Disease Pulmonary 2018 RESTRICTIVE LUNG DISEASES AND PULMONARY VASCULAR DISEASE Joel Thibodeaux, MD, Phone: 469-419-4535 Email: [email protected] INTRODUCTION This lecture will discuss basic concepts, etiologic factors, pathologic features, pathogenesis, and clinicopathologic findings in the different types of interstitial lung diseases. It also will touch briefly on pulmonary vascular diseases. LEARNING OBJECTIVES: • Acute respiratory distress syndrome (ARDS) (BP, pp. 460-461) o Define ARDS and list common causes o Illustrate the mechanism of lung injury in ARDS and the role of proinflammatory and anti-inflammatory mediators o Describe the morphologic features of ARDS. Understand how they evolve, and know what happens if the patient survives. • Diffuse interstitial lung disease (BP, pp. 472-474, 480-482) o List the major forms of diffuse interstitial lung diseases discussed o Be able to identify classic morphologic features of common interstitial lung diseases. o Recognize the major causes of pneumoconioses (BP, pp. 474-478) o Delineate the gross and microscopic features resulting from exposure to coal dust, silica, organic/animal dust, and asbestos. o Sarcoidosis (BP, pp. 478-480) . Define sarcoidosis . List the most common organs involved, and describe the characteristic histologic lesion . Describe the radiographic, gross, and histologic appearance of lesions in the hilar lymph nodes and lungs • Define primary pulmonary hypertension. Recognize the characteristic histologic
    [Show full text]
  • Idiopathic Bronchiolocentric Interstitial Pneumonia Samuel A
    Idiopathic Bronchiolocentric Interstitial Pneumonia Samuel A. Yousem, MD, Sanja Dacic, MD, PhD Department of Pathology, University of Pittsburgh Medical Center, Presbyterian University Hospital, Pittsburgh, Pennsylvania plugs of fibromyxoid connective tissue, and poorly The authors report 10 patients with a distinctive formed granulomas (1–3). This triad of morphologic idiopathic bronchiolocentric interstitial pneumonia changes allows the pathologist to direct the pulmo- having some histologic similarities to hypersensitiv- nologist to question the patient for specific inhala- ity pneumonitis. Bronchiolocentric interstitial tional exposures. We have accumulated 10 cases pneumonia has a marked predilection for women that have very similar morphologic findings to hy- (80%) and occurs in middle age (40–50 years). Chest persensitivity pneumonitis, with the exclusion of radiographs and pulmonary function tests show in- interstitial granulomas, in which extensive investi- terstitial and restrictive lung disease, while the his- gations failed to reveal a cause for the inflamma- tologic appearance is that of a centrilobular inflam- tion. The clinicopathologic features of this idio- matory process with small airway fibrosis and pathic bronchiolocentric interstitial pneumonia are inflammation that radiates into the interstitium of the basis of this report which suggests a more ag- the distal acinus in a patchy fashion. Granulomas gressive and life threatening biologic behavior for are not identified. At a mean followup of approxi- bronchiolocentric interstitial pneumonia than nor- mately 4 years in nine patients, 33% of patients mally associated with hypersensitivity pneumonitis were dead of disease and 56% had persistent or or some of the other conditions in the histologic progressive disease suggesting a more aggressive differential diagnosis. course than hypersensitivity pneumonitis and non- specific interstitial pneumonia, the two major dis- ease processes in the differential diagnosis.
    [Show full text]
  • BSL Lesson 13
    Physiology Lessons Lesson 13 for use with the PULMONARY FUNCTION II Biopac Student Lab Pulmonary Flow Rates Forced Expiratory Volume (FEV1,2,3) PC under Windows 95/98/NT 4.0/2000 Maximal Voluntary Ventilation (MVV) or Macintosh Manual Revision 12132000.PL3.6.6-ML3.0.7 Number of cycles in 12 second interval Average Volume Richard Pflanzer, Ph.D. per cycle Associate Professor Indiana University School of Medicine Purdue University School of Science J.C. Uyehara, Ph.D. Biologist Number of cycles/minute = Number of cycles in 12 second interval X 5 MVV = (Average volume per cycle) X (Number of cycles per minute) BIOPAC Systems, Inc. William McMullen Vice President BIOPAC Systems, Inc. BIOPAC Systems, Inc. 42 Aero Camino, Santa Barbara, CA 93117 (805) 685-0066, Fax (805) 685-0067 Email: [email protected] Web Site: http://www.biopac.com Page 2 Lesson 13: Pulmonary Function II Biopac Student Lab V3.0 I. INTRODUCTION The respiratory or pulmonary system performs the important functions of supplying oxygen (O2) during inhalation, removing carbon dioxide (CO2) during exhalation, and adjusting the acid-base balance (pH) of the body by removing acid-forming CO2. Because oxygen is necessary for cellular metabolism, the amount of air that the pulmonary system provides is important in setting the upper limits on work capacities or metabolism. Therefore, the measurement of lung volumes and the rate of air movement (airflow) are important tools in assessing the health and capacities of a person. In this lesson, you will measure: Forced Vital Capacity (FVC), which is the maximal amount of air that a person can forcibly exhale after a maximal inhalation.
    [Show full text]
  • Standardisation of Spirometry
    Eur Respir J 2005; 26: 319–338 DOI: 10.1183/09031936.05.00034805 CopyrightßERS Journals Ltd 2005 SERIES ‘‘ATS/ERS TASK FORCE: STANDARDISATION OF LUNG FUNCTION TESTING’’ Edited by V. Brusasco, R. Crapo and G. Viegi Number 2 in this Series Standardisation of spirometry M.R. Miller, J. Hankinson, V. Brusasco, F. Burgos, R. Casaburi, A. Coates, R. Crapo, P. Enright, C.P.M. van der Grinten, P. Gustafsson, R. Jensen, D.C. Johnson, N. MacIntyre, R. McKay, D. Navajas, O.F. Pedersen, R. Pellegrino, G. Viegi and J. Wanger CONTENTS AFFILIATIONS Background ............................................................... 320 For affiliations, please see Acknowledgements section FEV1 and FVC manoeuvre .................................................... 321 Definitions . 321 CORRESPONDENCE Equipment . 321 V. Brusasco Requirements . 321 Internal Medicine University of Genoa Display . 321 V.le Benedetto XV, 6 Validation . 322 I-16132 Genova Quality control . 322 Italy Quality control for volume-measuring devices . 322 Fax: 39 103537690 E-mail: [email protected] Quality control for flow-measuring devices . 323 Test procedure . 323 Received: Within-manoeuvre evaluation . 324 March 23 2005 Start of test criteria. 324 Accepted after revision: April 05 2005 End of test criteria . 324 Additional criteria . 324 Summary of acceptable blow criteria . 325 Between-manoeuvre evaluation . 325 Manoeuvre repeatability . 325 Maximum number of manoeuvres . 326 Test result selection . 326 Other derived indices . 326 FEVt .................................................................. 326 Standardisation of FEV1 for expired volume, FEV1/FVC and FEV1/VC.................... 326 FEF25–75% .............................................................. 326 PEF.................................................................. 326 Maximal expiratory flow–volume loops . 326 Definitions. 326 Equipment . 327 Test procedure . 327 Within- and between-manoeuvre evaluation . 327 Flow–volume loop examples. 327 Reversibility testing . 327 Method .
    [Show full text]
  • Interrelationship Between Lung Volume, Expiratory Flow, and Lung Transfer Factor in Fibrosing Alveolitis
    Thorax: first published as 10.1136/thx.36.11.858 on 1 November 1981. Downloaded from thorax 1981 ;36:858-862 Interrelationship between lung volume, expiratory flow, and lung transfer factor in fibrosing alveolitis JN PANDE From the Respiratory Laboratory, All India Institute of Medical Sciences, Ansari Nagar, New Delhi, India ABSTRACT Fifty patients with fibrosing alveolitis studied on 104 occasions exhibited significant direct correlations between vital capacity (VC), maximum mid-expiratory flow rate (MMFR), and transfer factor for carbon monoxide (TLCO). Forced expired volume in the first second (FEV,)/VC ratio bore a weak negative correlation with VC. Peak expiratory flow, MMFR, and maximum flow rates at 50 % and 25 % of VC were often reduced in patients with severe grades of pulmonary dys- function. It appears that as the severity of the fibrotic process increases, the lung volumes shrink and the transfer factor for CO decreases. The total lung capacity decreases predominantly on account of reduction in VC. With a decrease in lung volume the MMFR also falls. Decrease in flow rates at low lung volumes is greater as compared to the fall in peak flow. The expiratory flow rates how- ever were normal or even increased when related to absolute lung volume. Some patients exhibit disproportionate expiratory slowing as evidenced by a decrease in MMFR which is out of propor- tion to the reduction in VC. These patients also have a reduced FEV1,/VC ratio. These changes are probably the consequence of associated peripheral airway narrowing. copyright. Increased elastic recoil of the lung limiting maximal 33 women. Their age ranged from 16-68 years (mean inflation is considered to be the main abnormality of ± SE 42-1 ± 1-7 years).
    [Show full text]
  • Restrictive Lung Disease in Patients with Subclinical Coronavirus Infection: Are We Bracing Ourselves for Devastating Sequelae?
    Open Access Case Report DOI: 10.7759/cureus.12501 Restrictive Lung Disease in Patients With Subclinical Coronavirus Infection: Are We Bracing Ourselves for Devastating Sequelae? Rahul Dadhwal 1 , Munish Sharma 2 , Salim Surani 2, 3 1. Pulmonary Medicine, Corpus Christi Medical Center, Corpus Christi, USA 2. Internal Medicine, Corpus Christi Medical Center, Corpus Christi, USA 3. Internal Medicine, University of North Texas, Dallas, USA Corresponding author: Salim Surani, [email protected] Abstract The coronavirus disease 2019 (COVID-19) pandemic has affected millions of people worldwide. The manifestations of COVID-19 infection can range from being asymptomatic to developing severe acute respiratory distress syndrome (ARDS). Here, we present a case series of five patients who were either asymptomatic or had very mild symptoms of COVID-19 infection upon diagnosis. These patients neither required a visit to the emergency department (ED) nor did they need to be hospitalized but became symptomatic and were found to have interstitial lung disease four to eight weeks after a COVID-19 diagnosis. Thus, it is imperative that we routinely follow up patients with a subclinical COVID 19 infection besides those who were symptomatic. We may be witnessing a silent surge and new-onset interstitial lung disease (ILD) as sequelae of COVID 19 infection. Categories: Internal Medicine, Pulmonology Keywords: covid-19 infection, interstitial lung disease, restrictive lung disease, ground-glass opacities, angiotensin- converting enzyme 2, pulmonary fibrosis, post-covid sequelae, sars-cov-2 Introduction In December 2019, a novel coronavirus was recognized to be the cause of the agglomeration of pneumonia cases in Wuhan city located in the Hubei province of China, which rapidly spread, resulting in a global pandemic [1].
    [Show full text]
  • Experiment HS-8: Restrictive and Obstructive Airway Diseases This Lab Was Written in Conjunction with Dr
    Experiment HS-8: Restrictive and Obstructive Airway Diseases This lab was written in conjunction with Dr. Debra Mullikin-Kilpatrick of Boston College. Background The lung is the organ for gas (O2 and CO2) exchange. The lung transfers oxygen from the air into the blood and carbon dioxide from the blood into the air. To accomplish this gas exchange the lung has two components; airways and alveoli (air sacs). Airways are the branching, tubular passages that allow air to move in and out of the lungs. The wider segments are the trachea and the two bronchi, the smaller segments are bronchioles. At the ends of the bronchioles are the alveoli. Small blood capillaries are found in the walls of the alveoli. It is across the thin walls of the alveoli where gas exchange between the air and the blood takes place. Breathing involves inspiration and exhalation of air. During inspiration, muscles of the diaphragm and the rib cage contract and expand the size of the chest causing negative pressure within the airways and alveoli. As a result, air is pulled through the airways and into the alveoli and the chest wall is enlarged. During exhalation, the same muscles relax and the chest wall springs back to its resting positions, shrinking the chest and creating positive pressure within the airways and alveoli. As a result, air is expelled from the lungs. There are certain diseases that affect the way air is brought into and expelled out of the lungs. These diseases can be tricky to understand, due to the fact that if a person does not have the disease, it is hard to gain an understanding of how the disease affects others.
    [Show full text]
  • Errors in the Measurement of Vital Capacity a Comparison of Three Methods in Normal Subjects and in Patients with Pulmonary Emphysema
    Thorax: first published as 10.1136/thx.28.5.584 on 1 September 1973. Downloaded from Thorax (1973), 28, 584. Errors in the measurement of vital capacity A comparison of three methods in normal subjects and in patients with pulmonary emphysema D. C. S. HUTCHISON, C. E. BARTER', and N. A. MARTELLI2 Chest Unit, King's College Hospital, London SE5 Hutchison, D. C. S., Barter, C. E., and Martelli, N. A. (1973). Thorax, 28, 584-587. Errors in the measurement of vital capacity: a comparison of three methods in normal subjects and in patients with pulmonary emphysema. Three methods of measuring the vital capacity have been compared in six normal subjects and in six with pulmonary emphysema, according to a randomized design. The methods were (a) the inspiratory vital capacity (IVC), (b) the expiratory vital capacity (EVC), and (c) the forced vital capacity (FVC). In normal subjects, there was a small but significant difference between the methods. The residual standard deviation derived from analysis of variance was 94 ml (coefficient of variation 1.7 %). A slight but significant rise in vital capacity with repeated effort was observed. In emphysematous subjects, there was no significant difference between the IVC and EVC methods. The FVC gave values which were, on average, approximately 0.5 litre less copyright. than those obtained by the other methods. The standard deviation in all three methods was substantially greater than for the normal subjects. The FVC is not a suitable method for the measurement of vital capacity in patients with pulmonary emphysema. The EVC is satisfactory, provided it is used with caution, but in practice the IVC is the preferred method.
    [Show full text]
  • Alternative Methods for Assessing Bronchodilator Reversibility In
    Thorax 2001;56:713–720 713 Alternative methods for assessing bronchodilator Thorax: first published as 10.1136/thx.56.9.713 on 1 September 2001. Downloaded from reversibility in chronic obstructive pulmonary disease J Hadcroft, P M A Calverley Abstract Chronic obstructive pulmonary disease Background—Bronchodilator reversibil- (COPD) is characterised by airflow limitation ity testing is recommended in all patients which varies little over several months of with chronic obstructive pulmonary dis- observation or after treatment.12 The assess- ease (COPD) but does not predict im- ment of airflow limitation usually relies on provements in breathlessness or exercise spirometric testing and, in particular, the performance. Two alternative ways of forced expiratory volume in 1 second (FEV1) assessing lung mechanics—measurement which is the usual outcome measure in of end expiratory lung volume (EELV) diagnostic bronchodilator reversibility testing.3 using the inspiratory capacity manoeuvre Although useful diagnostically and prognosti- and application of negative expiratory cally,4 spirometric abnormalities are poor pressure (NEP) during tidal breathing to descriptors of the severity of breathlessness in detect tidal airflow limitation—do relate 5 COPD. Likewise, significant changes in FEV1 to the degree of breathlessness in COPD. after inhaled bronchodilators are not necessary Their usefulness as end points in broncho- for improvement in exercise performance or dilator reversibility testing has not been dyspnoea to occur.5–7 Two alternative tech- examined. niques of measuring lung mechanics relatively Methods—We studied 20 patients with easily are now available. Both are better corre- clinically stable COPD (mean age 69.9 lates of breathlessness than FEV , but their (1.5) years, 15 men, forced expiratory vol- 1 reproducibility and sensitivity to change in ume in one second (FEV ) 29.5 (1.6)% pre- 1 response to bronchodilator drugs has not been dicted) with tidal flow limitation as assessed—an important consideration if they assessed by their maximum flow-volume loop.
    [Show full text]
  • Respiratory System Chapter 23
    Respiratory System Chapter 23 Pulmonary Volumes and Capacities FIGURE 23.15 1. A spirometer is a device for measuring the volumes of air that move into and out of the respiratory system. Spirometry is the process of taking the measurements. 2. There are four pulmonary volumes. A. Tidal volume is the amount of air that moves in or out of the respiratory system during normal, quiet, at rest breathing. B. Inspiratory reserve is the amount of air that can be taken into the lungs following a normal tidal volume. It is the amount of air "on top" of the tidal volume. C. Expiratory reserve is the amount of air that can be forced out of the lungs following a normal tidal volume. It is the amount of air "below" the tidal volume. D. Residual volume is the amount of air that remains in the lungs after the expiratory reserve. It is the volume of air that cannot be eliminated from the lungs. E. Pulmonary volumes for a young adult male: Tidal volume 500 mL Inspiratory reserve 3000 mL Expiratory reserve 1100 mL Residual volume 1200 mL 3. A pulmonary capacity is two or more pulmonary volumes added together. A. Inspiratory capacity is tidal volume plus inspiratory reserve. This is the amount of air a person can inspire after a normal expiration. B. Functional residual capacity is the expiratory reserve volume plus the residual volume. This is the amount of air in the lungs after a normal expiration. C. Vital capacity is the expiratory reserve plus the tidal volume plus the inspiratory reserve.
    [Show full text]